Recent Publications:

Gibbs, E.M., Marshall, J.L., Ma, E., Nguyen, T.M., Hong, G., Lam, J.S., Spencer, M.J., Crosbie-Watson, R.H., 2016. High levels of sarcospan are well tolerated and act as a sarcolemmal stabilizer to address skeletal muscle and pulmonary dysfunction in DMD. Hum Mol Genet.

McMorran, B.J., McCarthy, F.E., Gibbs, E.M., Pang, M., Marshall, J.L., Nairn, A.V., Moremen, K.W., Crosbie-Watson, R.H., Baum, L.G., 2016. Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx. Glycobiology.

Marshall, J.L., Oh, J., Chou, E., Lee, J.A., Holmberg, J., Burkin, D.J., Crosbie-Watson, R.H., 2015. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and alpha7 integrin. Hum Mol Genet 24, 2011–2022.

Parvatiyar, M.S., Marshall, J.L., Nguyen, R.T., Jordan, M.C., Richardson, V.A., Roos, K.P., Crosbie-Watson, R.H., 2015. Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated Cardiomyopathy. J Am Heart Assoc 4.

Marshall, J.L., Kwok, Y., McMorran, B.J., Baum, L.G., Crosbie-Watson, R.H., 2013. The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy. FEBS J 280, 4210–4229.

Marshall, J.L., Crosbie-Watson, R.H., 2013. Sarcospan: a small protein with large potential for Duchenne muscular dystrophy. Skelet Muscle 3, 1.

Cabrera, P.V., Pang, M., Marshall, J.L., Kung, R., Nelson, S.F., Stalnaker, S.H., Wells, L., Crosbie-Watson, R.H., Baum, L.G., 2012. High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding. J Biol Chem 287, 22759–22770.

Marshall, J.L., Chou, E., Oh, J., Kwok, A., Burkin, D.J., Crosbie-Watson, R.H., 2012. Dystrophin and utrophin expression require sarcospan: loss of alpha7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice. Hum Mol Genet 21, 4378–4393.

Marshall, J.L., Holmberg, J., Chou, E., Ocampo, A.C., Oh, J., Lee, J., Peter, A.K., Martin, P.T., Crosbie-Watson, R.H., 2012. Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration. J Cell Biol 197, 1009–1027.

Previous Publications:

Rutkowski, A., Bonnemann, C., Brown, S., Thorsteinsdottir, S., Dominov, J., Ruegg, M.A., Matter, M.L., Guttridge, D., Crosbie-Watson, R.H., Kardon, G., Nagaraju, K., Girgenrath, M., Burkin, D.J., 2013. Report on the Myomatrix Conference April 22-24, 2012, University of Nevada, Reno, Nevada, USA. Neuromuscul Disord 23, 188–191.

Crawford GC, Faulkner JA, Crosbie RH, Campbell KP, Froehner SC, Chamberlain JS Assembly of the Dystrophin Associated Protein Complex Does Not Require the Dystrophin C-terminal Domain. J. Cell Biol 2000; 150: 1411-1422.

Crosbie RH et al. Molecular and Genetic Characterization of Sarcospan:Insights into Sarcoglycan-Sarcospan Domains. Hum. Mol. Genet. 2000; 9: 2019-2027.

Crosbie RH News and Views: NO Vascular Control in Duchenne Muscular Dystrophy. Nature Med 2000; 7: 27-29.

Holt KH, Crosbie RH, Venzke DP, Campbell KP Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS letters. . 2000; 468(1): 79-83.

Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, Grady RM, Chamberlain JS, Sanes JR, Campbell KP Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J. Cell Biol. . 1999; 145(1): 153-65.

Crosbie RH, Yamada H, Venzke DP, Lisanti MP, Campbell KP Caveolin-3 is Not an Integral Component of the Dystrophin-Glycoprotein Complex. FEBS Lett 1998; 427: 279-282.

Crosbie RH, Straub V, Yun HY, Lee JC, Rafael JA, Chamberlain JS, Dawson VL, Dawson TM, Campbell KP mdx muscle pathology is independent of nNOS perturbation. Hum. Mol. Genet. 1998; 7(5): 823-9.

Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R, Campbell KP Progressive Muscular Dystrophy in alpha-Sarcoglycan Deficient Mice. J. Cell Biol 1998; 142: 1461-1471.

Crosbie RH, Heighway J, Venzke DP, Lee JC, Campbell KP Sarcospan: The 25kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex. J. Biol. Chem 1997; 272: 31221-31224.

Campbell KP, Crosbie RH NEWS AND VIEWS: Utrophin to the Rescue. Nature 1996; 384: 308-309.

Crosbie RH, Chalovich JM, Reisler E Flexation of caldesmon: effect of conformation on the properties of caldesmon. J. Muscle Res. Cell Mot. . 1995; 16(5): 509-18.

Crosbie RH, Miller C, Cheung P, Goodnight T, Muhlrad A, Reisler E Structural connectivity in actin: effect of C-terminal modifications on the properties of actin. Biophysical J. . 1994; 67(5): 1957-64.

Crosbie RH, Miller C, Chalovich JM, Rubenstein PA, Reisler E Caldesmon, N-terminal yeast actin mutants, and the regulation of actomyosin interactions. Biochemistry. . 1994; 33(11): 3210-6.

Crosbie RH, Chalovich JM, Reisler E Interaction of caldesmon and myosin subfragment 1 with the C-terminus of actin. Biochem. Biophys. Res. Comm. . 1992; 184(1): 239-45.

Crosbie R, Adams S, Chalovich JM, Reisler E The interaction of caldesmon with the COOH terminus of actin. J. Biol. Chem. . 1991; 266(30): 20001-6.

Nelson Stanley F, Crosbie Rachelle H, Miceli M Carrie, Spencer Melissa J Emerging genetic therapies to treat Duchenne muscular dystrophy. Current opinion in neurology. 2009; 22(5): 532-8.

Kim Michelle H, Kay Danielle I, Rudra Renuka T, Chen Bo Ming, Hsu Nigel, Izumiya Yasuhiro, Martinez Leonel, Spencer Melissa J, Walsh Kenneth, Grinnell Alan D, Crosbie Rachelle H Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice. Hum. Mol. Genet. 2011; 20(7): 1324-38.

Merveille AC1, Davis EE, Becker-Heck A, Legendre M, Amirav I, Bataille G, Belmont J, Beydon N, Billen F, Clément A, Clercx C, Coste A, Crosbie R, de Blic J, Deleuze S, Duquesnoy P, Escalier D, Escudier E, Fliegauf M, Horvath J, Hill K, Jorissen M, Just J, Kispert A, Lathrop M, Loges NT, Marthin JK, Momozawa Y, Montantin G, Nielsen KG, Olbrich H, Papon JF, Rayet I, Roger G, Schmidts M, Tenreiro H, Towbin JA, Zelenika D, Zentgraf H, Georges M, Lequarré AS, Katsanis N, Omran H, Amselem S. CCDC39 is required for assembly of inner dynein arms and the dynein regulatory complex and for normal ciliary motility in humans and dogs. Nature genetics. 2011; 43(1): 72-8.

Solares-Pérez Alhondra, Alvarez Rocío, Crosbie Rachelle H, Vega-Moreno Jesús, Medina-Monares Joel, Estrada Francisco J, Ortega Alicia, Coral-Vazquez Ramón Altered calcium pump and secondary deficiency of gamma-sarcoglycan and microspan in sarcoplasmic reticulum membranes isolated from delta-sarcoglycan knockout mice. Cell calcium. 2010; 48(1): 28-36.

Marshall Jamie L, Holmberg Johan, Chou Eric, Ocampo Amber C, Oh Jennifer, Lee Joy, Peter Angela K, Martin Paul T, Crosbie-Watson Rachelle H Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration. J. Cell Biol. 2012; 197(7): 1009-27.

Rutkowski Anne, Bonnemann Carsten, Brown Susan, Thorsteinsdattir Salveig, Dominov Janice, Ruegg Markus A, Matter Michelle L, Guttridge Denis, Crosbie-Watson Rachelle H, Kardon Gabrielle, Nagaraju Kanneboyina, Girgenrath Mahasweta, Burkin Dean J Report on the Myomatrix Conference April 22-24, 2012, University of Nevada, Reno, Nevada, USA. Neuromusc. Dis. : NMD. 2012; .

Marshall Jamie L, Chou Eric, Oh Jennifer, Kwok Allan, Burkin Dean J, Crosbie-Watson Rachelle H Dystrophin and utrophin expression require sarcospan: loss of alpha7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice. Hum. Mol. Genet. 2012; .

Cabrera Paula V, Pang Mabel, Marshall Jamie L, Kung Raymond, Nelson Stanley F, Stalnaker Stephanie H, Wells Lance, Crosbie-Watson Rachelle H, Baum Linda G High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding. J. Biol. Chem. 2012; 287(27): 22759-70.

Marshall Jamie L, Crosbie-Watson Rachelle H Sarcospan: a small protein with large potential for Duchenne muscular dystrophy. Skeletal Muscle. 2013; 3(1): 1.

Marshall Jamie L, Kwok Yukwah, McMorran Brian J, Baum Linda G, Crosbie-Watson Rachelle H The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy. The FEBS journal. 2013; 280(17): 4210-29.